Cargando…

A nasal vaccine with inactivated whole-virion elicits protective mucosal immunity against SARS-CoV-2 in mice

INTRODUCTION: Vaccinations are ideal for reducing the severity of clinical manifestations and secondary complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, SARS-CoV-2 continues to cause morbidity and mortality worldwide. In contrast to parenteral vaccines such as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tokunoh, Nagisa, Tamiya, Shigeyuki, Watanabe, Masato, Okamoto, Toru, Anindita, Jessica, Tanaka, Hiroki, Ono, Chikako, Hirai, Toshiro, Akita, Hidetaka, Matsuura, Yoshiharu, Yoshioka, Yasuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500122/ https://www.ncbi.nlm.nih.gov/pubmed/37720231 http://dx.doi.org/10.3389/fimmu.2023.1224634

Ejemplares similares

Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses preexisting immunity to enhance antigen-specific responses
por: Kawai, Atsushi, et al.
Publicado: (2023)

Synergistic effect of non-neutralizing antibodies and interferon-γ for cross-protection against influenza
por: Shibuya, Meito, et al.
Publicado: (2021)

Baculovirus as a Tool for Gene Delivery and Gene Therapy
por: Ono, Chikako, et al.
Publicado: (2018)

SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression
por: Hashimoto, Rina, et al.
Publicado: (2022)

Upregulation of Robo4 expression by SMAD signaling suppresses vascular permeability and mortality in endotoxemia and COVID-19 models
por: Morita, Maaya, et al.
Publicado: (2023)

Considerations of CD8(+) T Cells for Optimized Vaccine Strategies Against Respiratory Viruses
por: Hirai, Toshiro, et al.
Publicado: (2022)

Susceptibility Analysis in Several Mouse Strains Reveals Robust T-Cell Responses After Mycoplasma pneumoniae Infection in DBA/2 Mice
por: Tamiya, Shigeyuki, et al.
Publicado: (2021)

Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production
por: Herrera-Rodriguez, José, et al.
Publicado: (2019)

Complexes of Zinc With Picolinic and Aspartic Acids Inactivate Free Varicella-Zoster Virions
por: Shishkov, S., et al.
Publicado: (1996)

A promising inactivated whole-virion SARS-CoV-2 vaccine
por: Isakova-Sivak, Irina, et al.
Publicado: (2021)

Large-Scale Preparation of UV-Inactivated SARS Coronavirus Virions for Vaccine Antigen
por: Tsunetsugu-Yokota, Yasuko
Publicado: (2007)

Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure
por: Loveday, Emma K., et al.
Publicado: (2021)

Neutrophil-Mediated Lung Injury Both via TLR2-Dependent Production of IL-1α and IL-12 p40, and TLR2-Independent CARDS Toxin after Mycoplasma pneumoniae Infection in Mice
por: Tamiya, Shigeyuki, et al.
Publicado: (2021)

Allergic Responses Induced by the Immunomodulatory Effects of Nanomaterials upon Skin Exposure
por: Yoshioka, Yasuo, et al.
Publicado: (2017)

Chordopoxvirus protein F12 implicated in enveloped virion morphogenesis is an inactivated DNA polymerase
por: Yutin, Natalya, et al.
Publicado: (2014)

Surprisingly Effective Priming of CD8(+) T Cells by Heat-Inactivated Vaccinia Virus Virions
por: Croft, Sarah, et al.
Publicado: (2020)

Psoriasis Flare-Up After COVAXIN BBV152 Whole Virion Inactivated Vaccine
por: Infimate, DJ L, et al.
Publicado: (2022)

Mucosal and cellular immune responses elicited by nasal and intramuscular inoculation with ASFV candidate immunogens
por: Xu, Lulu, et al.
Publicado: (2023)

Long-Term Immunogenicity Studies of Formalin-Inactivated Enterovirus 71 Whole-Virion Vaccine in Macaques
por: Liu, Chia-Chyi, et al.
Publicado: (2014)

Immunogenicity and safety of the 2015 Southern Hemisphere formulation of a split-virion inactivated quadrivalent vaccine
por: Montalban, Cecilia, et al.
Publicado: (2017)

Atomic force microscopy analysis of native infectious and inactivated SARS-CoV-2 virions
por: Lyonnais, Sébastien, et al.
Publicado: (2021)

Tightly Regulated Expression of Autographa californica Multicapsid Nucleopolyhedrovirus Immediate Early Genes Emerges from Their Interactions and Possible Collective Behaviors
por: Ono, Chikako, et al.
Publicado: (2015)

Immunogenicity Studies of Bivalent Inactivated Virions of EV71/CVA16 Formulated with Submicron Emulsion Systems
por: Lin, Chih-Wei, et al.
Publicado: (2014)

Safety and tolerability of a 2009 trivalent inactivated split‐virion influenza vaccine in infants, children and adolescents
por: Lambert, Stephen B., et al.
Publicado: (2013)

Immunization strategies to elicit mucosal immune response of HIV
por: Shi, Yinghui
Publicado: (2006)

Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses
por: Shinnakasu, Ryo, et al.
Publicado: (2021)

Virion Structure and Composition
por: Burrell, Christopher J., et al.
Publicado: (2017)

Interactions of peptide triazole thiols with Env gp120 induce irreversible breakdown and inactivation of HIV-1 virions
por: Bastian, Arangassery Rosemary, et al.
Publicado: (2013)

Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in India
por: Agarkhedkar, Sharad, et al.
Publicado: (2019)

Central retinal artery occlusion after vaccination with whole virion inactivated SARSCoV- 2 vaccine Covaxin
por: Thakar, Meenakshi, et al.
Publicado: (2022)

The adjuvant effect of bacterium-like particles depends on the route of administration
por: Sudo, Haruka, et al.
Publicado: (2023)

Cross‐neutralisation of antibodies elicited by an inactivated split‐virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains
por: Höschler, Katja, et al.
Publicado: (2008)

Lipid Nanoparticles Potentiate CpG-Oligodeoxynucleotide-Based Vaccine for Influenza Virus
por: Shirai, Seiki, et al.
Publicado: (2020)

RF_phage virion: Classification of phage virion proteins with a random forest model
por: Zhang, Yanqin, et al.
Publicado: (2023)

A phenyl-thiadiazolylidene-amine derivative ejects zinc from retroviral nucleocapsid zinc fingers and inactivates HIV virions
por: Vercruysse, Thomas, et al.
Publicado: (2012)

Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
por: Zhang, Zhegang, et al.
Publicado: (2022)

Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination
por: Tavukcuoglu, Ece, et al.
Publicado: (2023)

Genomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 gene
por: Takada, Kosuke, et al.
Publicado: (2023)

Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China
por: Chen, Yaping, et al.
Publicado: (2022)

Native Morphology of Influenza Virions
por: Noda, Takeshi
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_si5mso389akc70lsk05688rtib